The novel class III antiarrhythmic agent MS-551 blocks the cardiac inward rectifier with greater potency than sotalol or E-4031: Possible relevance to reverse use dependence

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 2, Issue 1, 1997, Pages 39-46

  Nakaya, Y ^a   Martin, D K ^a   Campbell, T J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

cardiac action potential; class III antiarrhythmic drugs; E 4031; MS 551; potassium channel; sotalol; use dependence

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ANTIARRHYTHMIC AGENT; NIFEKALANT; POTASSIUM CHANNEL; SOTALOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030987799     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424849700200105     Document Type: Article

References (30)